Panic Attacks: When to See a Doctor and What to Expect

What a Panic Attack Actually Is

A panic attack is a discrete surge of intense fear that peaks within minutes, accompanied by at least four physical or cognitive symptoms defined in the DSM-5-TR. These symptoms include palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, chills or heat sensations, numbness, derealization, fear of losing control, and fear of dying 1.

The attack itself is not dangerous. It represents a misfiring of the sympathetic nervous system, the same fight-or-flight cascade that would protect you from a physical threat. The amygdala sends an alarm signal, the adrenal glands release epinephrine, heart rate climbs, and blood is shunted away from the gut toward skeletal muscle. All of this happens in seconds.

A single panic attack does not equal panic disorder. The DSM-5-TR requires recurrent unexpected attacks plus at least one month of persistent worry about future attacks, or maladaptive behavioral change (such as avoidance) related to the attacks, before diagnosing panic disorder [1]. Roughly 28% of adults who experience an isolated panic attack go on to develop full panic disorder within 12 months, according to data from the World Mental Health Survey Initiative [2].

When Panic Attacks Require Medical Attention

The short answer: sooner than most people think. Any first-time episode severe enough that you consider calling 911 warrants evaluation in an emergency department, because the symptom overlap between panic attacks and acute coronary syndrome, pulmonary embolism, and pheochromocytoma is significant 3.

Schedule an appointment with your primary care provider or a psychiatrist if you experience any of the following:

• Two or more attacks in a 30-day window
• Avoidance of specific places, driving, or social situations because of attack fear
• Persistent dread between attacks ("when will the next one hit?")
• Sleep disruption caused by nocturnal attacks, which affect roughly 44-71% of panic disorder patients per a 2014 review [4]
• New onset of agoraphobia (fear of situations where escape might be difficult)
• Substance use escalating as a coping strategy

Go to an emergency department immediately if chest pain radiates to the jaw or arm, if you lose consciousness, or if you have known cardiac risk factors (hypertension, diabetes, smoking, family history of early coronary disease). An ECG, troponin level, and D-dimer can typically distinguish cardiac events from panic within 60-90 minutes [3].

Why Panic Attacks Happen: Causes and Risk Factors

No single cause accounts for every case. Panic disorder arises from a convergence of genetic vulnerability, neurobiological dysregulation, and environmental stressors.

Genetics. Twin studies estimate heritability of panic disorder at 30-40% 5. First-degree relatives of a person with panic disorder are 4-8 times more likely to develop the condition than the general population.

Neurobiology. The "fear network" model implicates hyperactivity in the amygdala, insular cortex, and periaqueductal gray, along with deficient top-down inhibition from the prefrontal cortex. Dysregulation of serotonin (5-HT), norepinephrine, and gamma-aminobutyric acid (GABA) systems has been documented in neuroimaging and pharmacologic challenge studies [6].

Medical triggers to rule out. Hyperthyroidism, cardiac arrhythmias, mitral valve prolapse, pheochromocytoma, temporal lobe epilepsy, and stimulant use (caffeine, amphetamines, cocaine) can all produce panic-like symptoms. A thorough workup should include TSH, CBC, BMP, and an ECG at minimum [3].

Life stressors. Major transitions (job loss, divorce, bereavement), childhood adversity, and trauma exposure are well-established precipitants. The National Comorbidity Survey Replication found that 69% of panic disorder cases were comorbid with at least one other DSM disorder, most commonly major depression and generalized anxiety disorder [7].

How Panic Disorder Is Diagnosed

Diagnosis is clinical. No blood test or brain scan confirms panic disorder. Your doctor will use a structured approach.

Step 1: rule out medical mimics. This includes the lab and ECG workup described above. If you are over 50 with new-onset "panic," your provider should have a low threshold for stress testing or Holter monitoring to exclude arrhythmia 3.

Step 2: apply DSM-5-TR criteria. The clinician confirms recurrent unexpected panic attacks, at least one followed by a month or more of concern about additional attacks or maladaptive behavioral change 1.

Step 3: assess severity. The Panic Disorder Severity Scale (PDSS), a 7-item clinician-rated instrument, is considered the gold standard for tracking symptom burden and treatment response. A score of 8 or above (out of 28) generally indicates moderate severity warranting active treatment 8.

Step 4: screen for comorbidities. Because depression co-occurs in roughly half of panic disorder cases 7, validated screening tools such as the PHQ-9 (depression) and GAD-7 (generalized anxiety) should be administered at the initial visit.

The entire diagnostic process, from symptom history through initial labs, can typically be completed in one to two visits.

First-Line Treatment: SSRIs, SNRIs, and How They Work

Selective serotonin reuptake inhibitors are the most studied pharmacotherapy for panic disorder. The American Psychiatric Association practice guidelines recommend SSRIs or SNRIs as first-line agents [9].

Sertraline (Zoloft): FDA-approved for panic disorder. In a key 10-week randomized controlled trial (N=176), sertraline 50-200 mg/day produced a 50% greater reduction in panic attack frequency versus placebo 10.

Paroxetine (Paxil): also FDA-approved. A 10-week trial (N=278) showed 76% of paroxetine-treated patients were panic-free at endpoint, compared with 44% on placebo 11.

Venlafaxine XR (Effexor XR): FDA-approved SNRI. A pooled analysis of two trials (N=1,327) found 54% of patients on venlafaxine XR 75-225 mg were panic-free at week 12 vs. 34% on placebo 12.

The critical clinical point: start low. Patients with panic disorder are often exquisitely sensitive to activating side effects (jitteriness, insomnia) in the first 1-2 weeks. Standard practice is to begin at half the usual starting dose (e.g., sertraline 25 mg) and titrate slowly over 2-4 weeks 9.

Full anxiolytic benefit typically requires 4-6 weeks. If one SSRI fails after an adequate trial (8-12 weeks at therapeutic dose), switching to another SSRI or to venlafaxine XR is reasonable before escalating therapy.

The Role of Benzodiazepines: Short Leash, Clear Exit

Benzodiazepines (alprazolam, clonazepam, lorazepam) work fast. Alprazolam can abort a panic attack within 15-20 minutes. That speed made it the most-prescribed panic drug for decades.

The problem is well-documented. Benzodiazepines carry risks of physiologic dependence, rebound anxiety on discontinuation, cognitive blunting, and falls in older adults. The APA guidelines recommend limiting benzodiazepine use to a short-term bridge (2-4 weeks) while an SSRI is titrated to effect [9].

A Cochrane review of 23 trials confirmed benzodiazepines are effective for acute panic but found "no convincing evidence" of superiority over antidepressants at 8 weeks, with higher discontinuation syndrome rates [13]. Clonazepam, with its longer half-life (30-40 hours), is generally preferred over alprazolam for standing use because it produces fewer interdose rebound symptoms.

If a benzodiazepine has been used daily for longer than 4 weeks, taper gradually (typically a 10-25% dose reduction every 1-2 weeks) to avoid withdrawal seizures.

Cognitive-Behavioral Therapy: The Evidence Base

CBT for panic disorder is one of the most rigorously validated interventions in all of psychiatry. It is not talk therapy in the colloquial sense. It is a structured, manualized protocol with two core components:

Cognitive restructuring teaches patients to identify and challenge catastrophic misinterpretations of bodily sensations ("my heart is racing, so I must be having a heart attack").

Interoceptive exposure deliberately provokes feared sensations (hyperventilating, spinning in a chair, breathing through a straw) in a controlled setting, so the patient learns the sensations are uncomfortable but not dangerous.

A meta-analysis of 42 RCTs (N=2,909) found CBT produced large effect sizes (Cohen's d = 0.87) for panic symptom reduction compared with control conditions [14]. Response rates of 70-90% are reported across multiple trials, with 12-16 sessions as the standard protocol length.

The durability advantage is significant. In a 2-year follow-up study, 87% of CBT responders maintained their gains, compared to 37% of patients who had responded to imipramine alone and then discontinued medication [15].

CBT vs. medication head-to-head. A landmark NIMH-funded trial (N=312) compared CBT, imipramine, their combination, and placebo over 12 weeks of acute treatment. The CBT and imipramine groups showed comparable acute response rates (49% vs. 46%), but the CBT group had significantly lower relapse at 6-month follow-up 15.

Combination Therapy: When to Add a Second Modality

For moderate-to-severe panic disorder (PDSS score of 14 or above), the strongest evidence supports combining an SSRI with CBT from the start. A meta-analysis by Furukawa et al. (2007) pooled 21 RCTs and found that combination therapy was superior to either treatment alone during acute-phase treatment (NNT = 5 for combination vs. CBT alone) [16].

The clinical decision often comes down to access. CBT requires a trained therapist, typically 12-16 weekly sessions at $150-250 per session (often covered in part by insurance). Wait times in many U.S. metro areas exceed 2-3 months.

Practical sequencing for most patients:

1. Start an SSRI at low dose on day one.
2. Add a short-term benzodiazepine bridge if attacks are frequent (more than 2 per week) and functionally impairing.
3. Begin CBT as soon as a qualified therapist is available.
4. Taper the benzodiazepine within 4 weeks.
5. Continue the SSRI for at least 12 months after full remission before considering a slow taper.

The 12-month minimum is based on relapse data showing that discontinuation before 12 months is associated with relapse rates of 25-50% [17].

Lifestyle and Self-Management Strategies

Lifestyle modifications do not replace pharmacotherapy or CBT for diagnosed panic disorder, but they reduce overall autonomic reactivity and may decrease attack frequency.

Aerobic exercise. A randomized trial (N=56) found that 150 minutes per week of moderate-intensity aerobic exercise over 10 weeks reduced panic symptom severity by 30% compared with a control group, with improvements correlating to increased exercise capacity [18].

Caffeine reduction. Caffeine at doses above 400 mg (about 4 cups of brewed coffee) is a recognized panicogen. A 480 mg caffeine challenge induced full panic attacks in 61% of panic disorder patients vs. 12% of controls [19].

Sleep hygiene. Short sleep duration and poor sleep quality independently predict panic attack occurrence. The nocturnal panic attack subtype is more common in patients with comorbid insomnia 4.

Diaphragmatic breathing. While the evidence is modest, slow-paced breathing (5-6 breaths per minute) activates the vagal brake and reduces sympathetic tone. It is most useful as a coping skill taught within the CBT framework rather than as a standalone treatment.

Special Populations: Pregnancy, Adolescents, and Older Adults

Pregnancy. Panic disorder may worsen in the first trimester. Sertraline is generally considered the SSRI with the most reassuring reproductive safety data, per ACOG Committee Opinion 354 [20]. Benzodiazepines are avoided in pregnancy due to neonatal withdrawal risk.

Adolescents (ages 12-17). CBT is the preferred first-line treatment. If pharmacotherapy is needed, fluoxetine has the most pediatric safety data among SSRIs. The NICE guideline CG113 recommends 7-14 sessions of CBT before considering medication [21].

Older adults (65+). SSRIs remain first-line, but starting doses should be halved and titrated more slowly. Benzodiazepines carry a high risk of falls, hip fractures, and cognitive impairment in this population and should be avoided if at all possible 9.

When Panic Attacks Do Not Respond to Standard Treatment

About 20-30% of patients do not achieve full remission with first-line treatment. Options at this stage, supported by varying levels of evidence:

Switching SSRI class or adding an SNRI. If two SSRIs at adequate doses for adequate duration have failed, venlafaxine XR or a tricyclic antidepressant (clomipramine, imipramine) is a reasonable next step 9.

Augmentation. Adding a low-dose atypical antipsychotic (aripiprazole 2-5 mg, risperidone 0.25-0.5 mg) to an SSRI has shown benefit in small trials, though this is off-label and carries metabolic side-effect risk 22.

Intensive CBT. Compressed, daily-session formats (5-8 consecutive days) have shown comparable efficacy to weekly CBT in a Norwegian RCT (N=152), with 70% of the intensive group panic-free at 12 months [23].

The treatment-resistant workup should also revisit comorbidities. Undertreated PTSD, alcohol use disorder, or undetected bipolar II disorder can maintain panic symptoms despite otherwise appropriate therapy.

The Bottom Line

A panic attack that happens once is an alarm worth listening to. A panic attack that recurs, disrupts your routine, or sends you to the ER is a disorder that responds to treatment. Sertraline or paroxetine at an adequate dose for at least 12 months, combined with 12-16 sessions of interoceptive-exposure-based CBT, produces full remission in approximately 60-70% of patients. The first step is always ruling out medical causes with basic labs and an ECG. Book the appointment.